AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

Brivaracetam 25 Mg ;

10 registrations across 1 African market— 10 active

Markets with Brivaracetam 25 Mg ;

Recent registrations

Brand / ProductMarketHolderStatusExpires
Kativarox 25 mg
Film Coated Tablets
🇪🇬EgyptApex pharmaactive
Pilebriva 25 mg
Film Coated Tablets
🇪🇬EgyptHikma Pharmaceuticals industriesactive
Brivasizur 25 mg
Film Coated Tablets
🇪🇬EgyptGlobal Pharmaceutical Industriesactive
Varocetam 25 mg
Film Coated Tablets
🇪🇬EgyptGypto Pharma for Pharmaceutical Manufacturing and Trading - GYPTOactive
Convarsiotam 25 mg
Film Coated Tablets
🇪🇬EgyptMarcyrl pharmaceutical industries - MPIactive
Cetabrivara 25mg
Film Coated Tablets
🇪🇬EgyptRIVA PHARMAactive
Andolepsy 25mg
Film Coated Tablets
🇪🇬Egyptal andalous for pharmaceutical industriesactive
Brivasizur 25 mg
Film Coated Tablets
🇪🇬EgyptGlobal Pharmaceutical Industriesactive
Pilebriva 25 mg
Film Coated Tablets
🇪🇬EgyptHikma Pharmaceuticals industriesactive
Andolepsy 25mg
Film Coated Tablets
🇪🇬Egyptal andalous for pharmaceutical industriesactive

Brivaracetam 25 Mg ; in Africa — Regulatory Overview

Brivaracetam 25 Mg ; is registered across 1 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.

Of the 10 registrations, 10 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.